Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhanwang Pharmaceutical, frequently referred to in international trade as Zhejiang Excel Pharmaceutical, is a prominent Chinese manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs). Based in Huzhou, Zhejiang, the company specializes in the production of high-quality inactive ingredients such as hypromellose (HPMC), microcrystalline cellulose (MCC), and various starch derivatives essential for solid dosage forms. Additionally, it is a major global supplier of L-Carnitine and its derivatives for the pharmaceutical and nutraceutical markets. The company operates large-scale, GMP-certified facilities and was acquired by Anhui Sunhere Pharmaceutical Excipients in 2015, strengthening its position in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Excel Pharmaceutical.